Purchase Order 75N95020P00235
- Not listed
- This federal contract award to Acea Biosciences, Inc. was issued by the National Cancer Institute (NCI), a component of the U.S. Department of Health and Human Services. The contract, valued at $96,213.60, is for the procurement of a small footprint high-dimensional flow cytometer. This equipment will be used to support research activities within the NCI. The contract has a firm fixed price pricing type and a completion date of November 16, 2016. Acea Biosciences is a life sciences company...
- This federal contract award was made by the Food and Drug Administration (FDA) to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The contract is for the delivery of a flow cytometer with post-warranty service and maintenance options, for a total ceiling value of $53,640.00. The contract was awarded on a firm fixed-price basis, with no set-aside designation. Acea Biosciences has previously received numerous prime federal contract awards from various agencies, including the...
- This is a $17,498.00 firm fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian federal agency, to Acea Biosciences, Inc. The contract is for the delivery of specialized biological research equipment and services related to flow cytometry, cell analysis, and biosensing technology. Acea Biosciences is a life sciences company that has received numerous federal contract awards from various agencies to provide instruments,...
- This contract was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The contract is a firm fixed-price purchase order with a potential value of $134,995.95. There was no set-aside designation for this award. Acea Biosciences is a life sciences company that provides specialized equipment, software, services, and expertise related to flow...
- This federal contract award was made by the National Cancer Institute, a civilian agency within the U.S. Department of Health and Human Services, to Acea Biosciences, Inc. for the acquisition of an xCELLigence RTCA-MP equipment package. The $99,000.00 firm fixed-price purchase order does not have a set-aside designation. Acea Biosciences, a for-profit life sciences company, has received over 20 prior federal contract awards from agencies including the USDA, HHS, VA, and Navy to provide...
- This federal contract award, with ID 75N95019P00175, was made by the National Institute on Drug Abuse (NIDA), which is part of the Department of Health and Human Services (HHS), to Acea Biosciences, Inc. for the purchase of one (1) ACEA Novocyte Quanteon flow cytometer system with a Novosampler Q package. The $175,000.00 firm fixed-price purchase order did not utilize any set-aside designations. The original solicitation was a non-competitive pre-solicitation notice issued under simplified...
- This federal contract award to Acea Biosciences, Inc. is for a Real-Time Label-Free Cell Analysis System. The $83,000.00 firm-fixed-price purchase order was issued by the Food and Drug Administration (FDA), a civilian agency. The contract does not have a set-aside designation. Acea Biosciences, a for-profit organization, has received over 20 prime federal contracts from agencies including the Department of Agriculture, Department of Health and Human Services, Department of Veterans Affairs,...
- This is a one-year service agreement contract awarded to Acea Biosciences, Inc. by the National Institute of Child Health and Human Development (NICHD), a civilian agency under the Department of Health and Human Services. The $12,290.40 firm-fixed price contract is for the provision of a flow cytometer instrument and related services. There is no set-aside designation indicated. Acea Biosciences is a subsidiary of Agilent Technologies, Inc., a leading provider of analytical instruments,...
- This federal contract was awarded by the Department of the Navy Bureau of Medicine and Surgery to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $125,070.00 firm fixed price purchase order is for an XCELLIGENCE RTCA MP BUNDLE CAT# 00380601040, which is a real-time cell analysis system used in research laboratories. The contract does not have a set-aside designation. Acea Biosciences has received over 20 previous prime federal contracts from agencies like the Departments...
- This one-year firm fixed-price purchase order was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development to Acea Biosciences, Inc., a for-profit life sciences company that is a subsidiary of Agilent Technologies. The $8,705.70 contract is for an extended service warranty on a NovoCyte One laser system, which was likely procured by the NIH to support specialized research and testing. Acea Biosciences has...
This federal contract award was made by the National Institute on Drug Abuse, a civilian agency, to Acea Biosciences, Inc., a subsidiary of Agilent Technologies, Inc. The $4,987.50 firm fixed-price purchase order is for service agreement coverage of a NovoCyte Quanteon flow cytometer system and an xCELLigence RTCA CardioECR instrument. The award does not have a set-aside designation, indicating it was competed on a full and open basis. Acea Biosciences has received numerous prior federal contract awards from various agencies to provide specialized laboratory equipment, instruments, and related services to support scientific research efforts, demonstrating their capabilities in this domain. This contract award will enable the National Institute on Drug Abuse to maintain and service the critical flow cytometry and cell analysis instrumentation used in their research programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | ($15k) | 9/2/25 | |
| P00001 | Funding Only Action | ($19k) | 8/26/25 | |
| Not listed | Not listed | $38.8k | 6/3/20 |